Evidence map›Paper›PMID 28497011›Full record

ArticleCureus2017

Reference Data for Standardized Quality of Life Questionnaires in Indian Patients with Brain Metastases from Non-small Cell Lung Cancer: Results from a Prospective Study.

Jaiprakash Aggarwal, Santam Chakraborty, Sarbani Ghosh Laskar, Vijay M Patil, Kumar Prabhash, Atanu Bhattacharya, Vanita Noronha, Nilendu C Purandare, Amit Joshi, Naveen Mummudi and 2 more

Abstract read
In one paragraph

Article in Cureus, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Quality of life in adult patients with hematological malignancy- treading a road less travelled.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2025
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jaiprakash AggarwalDepartment of Radiation Oncology, Tata Memorial Hospital, Mumbai, India.
Santam ChakrabortyDepartment of Radiation Oncology, Tata Memorial Hospital, Mumbai, India.
Sarbani Ghosh LaskarDepartment of Radiation Oncology, Tata Memorial Hospital, Mumbai, India.
Vijay M PatilDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, India.
Kumar PrabhashDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, India.
Atanu BhattacharyaDepartment of Biostatistics, Malabar Cancer Center.
Vanita NoronhaDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, India.
Nilendu C PurandareDepartment of Nuclear Medicine, Tata Memorial Hospital, Mumbai, India.
Amit JoshiDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, India.
Naveen MummudiDepartment of Radiation Oncology, Tata Memorial Hospital, Mumbai, India.
Jitendra AroraDepartment of Radiation Oncology, Tata Memorial Hospital, Mumbai, India.
Rupali BadheDepartment of Radiation Oncology, Tata Memorial Hospital, Mumbai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionReference data for European Organization for Research and Treatment of Cancer (EORTC) quality of life questionnaires do not include studies from the Indian subcontinent. The objective of the current study was to establish a reference dataset for Indian patients of non-small cell lung cancer (NSCLC) presenting with brain metastases (BM). MATERIAL AND

methodsOne hundred forty patients with NSCLC with BM treated between 2012-2015 were registered in a prospective cohort study (CTRI/2013/01/003299). The baseline quality of life was evaluated using the EORTC general quality of life questionnaire QLQ-C30 and lung cancer specific module LC13. Minimum important difference (MID) scores for individual domains of the EORTC QLQ-C30 and LC13 questionnaires were derived (MID = 0.2 x standard deviation) from the reference data for patients with recurrent/metastatic lung cancers. In addition, a systematic review was conducted to identify studies reporting baseline quality of life scores for recurrent/metastatic NSCLC.

resultsScores of several functional as well as symptom scales in the current NSCLC population differed by more than the MID from the baseline mean scores in the reference EORTC population as well as that reported from other studies. Differences in mean score from the EORTC reference data ranged from 6.2 and 9.4 points for the role functioning and cognitive functioning domains. In the symptom scales, the largest differences were observed for the financial difficulties (23.9) scores for the QLQ-C30 and peripheral neuropathy (21.7) for LC13 questionnaires.

conclusionThe current study demonstrates that baseline reference scores need to be established for patients from the Indian subcontinent. The findings from the current study have important implications for studies employing quality of life (QOL) assessment in the Indian NSCLC patient population.

Indexed as

brain metastaseseortc lc13eortc qlq c30eortc quality of lifehealth-related quality of lifeindian experiencelung cancernon-small cell lung cancers (nsclc)reference datawhole brain radiation therapy

Identifiers

PMID28497011
PMCPMC5425287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.